Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Santoesha A Ghisai

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neuro-Oncology Advances|February 17, 2025
Transcriptomic analysis of <i>EGFR</i> co-expression and activation in glioblastoma reveals associations with its ligandsSantoesha A Ghisai, Nastaran Barin, Levi van Hijfte, et al.
Nature Communications|January 29, 2025
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytomaLevi van Hijfte, Marjolein Geurts, Iris de Heer, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytomaSantoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Acta Neuropathologica|October 9, 2024
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytomaSantoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Cancer Cell|March 10, 2023
Transcriptome analysis reveals tumor microenvironment changes in glioblastomaYouri Hoogstrate, Kaspar Draaisma, Santoesha A Ghisai, et al.
Neuro-Oncology|October 5, 2021
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysisYouri Hoogstrate, Santoesha A Ghisai, Maurice de Wit, et al.
Cell Reports. Medicine|March 18, 2026
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomasYouri Hoogstrate, Santoesha A Ghisai, Levi van Hijfte, et al.
The Lancet. Oncology|December 25, 2025
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trialMartin J van den Bent, Santoesha A Ghisai, Wolfgang Wick, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neuro-Oncology Advances|February 17, 2025
Transcriptomic analysis of <i>EGFR</i> co-expression and activation in glioblastoma reveals associations with its ligandsSantoesha A Ghisai, Nastaran Barin, Levi van Hijfte, et al.
Nature Communications|January 29, 2025
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytomaLevi van Hijfte, Marjolein Geurts, Iris de Heer, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytomaSantoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Acta Neuropathologica|October 9, 2024
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytomaSantoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Cancer Cell|March 10, 2023
Transcriptome analysis reveals tumor microenvironment changes in glioblastomaYouri Hoogstrate, Kaspar Draaisma, Santoesha A Ghisai, et al.
Neuro-Oncology|October 5, 2021
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysisYouri Hoogstrate, Santoesha A Ghisai, Maurice de Wit, et al.
Cell Reports. Medicine|March 18, 2026
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomasYouri Hoogstrate, Santoesha A Ghisai, Levi van Hijfte, et al.
The Lancet. Oncology|December 25, 2025
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trialMartin J van den Bent, Santoesha A Ghisai, Wolfgang Wick, et al.
Pageof 1